IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
177.39
-1.97 (-1.10%)
At close: Mar 28, 2025, 4:00 PM
178.18
+0.79 (0.44%)
After-hours: Mar 28, 2025, 8:00 PM EDT
IQVIA Holdings Market Cap
IQVIA Holdings has a market cap or net worth of $31.28 billion as of March 28, 2025. Its market cap has decreased by -32.59% in one year.
Market Cap
31.28B
Enterprise Value
43.92B
1-Year Change
-32.59%
Ranking
Category
Stock Price
$177.39
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from $5.46B to $31.28B, an increase of 473.07%. That is a compound annual growth rate of 15.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 31.24B | -12.42% |
| Dec 31, 2024 | 35.67B | -15.54% |
| Dec 29, 2023 | 42.23B | 10.96% |
| Dec 30, 2022 | 38.06B | -29.39% |
| Dec 31, 2021 | 53.90B | 56.91% |
| Dec 31, 2020 | 34.35B | 14.58% |
| Dec 31, 2019 | 29.98B | 27.57% |
| Dec 31, 2018 | 23.50B | 13.60% |
| Dec 29, 2017 | 20.69B | 10.50% |
| Dec 30, 2016 | 18.72B | 121.52% |
| Dec 31, 2015 | 8.45B | 12.33% |
| Dec 31, 2014 | 7.52B | 25.93% |
| Dec 31, 2013 | 5.97B | 9.47% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |